Cite Filings / NRIX / 0001104659-20-089591
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Nurix Therapeutics, Inc. · Filed 2020-08-03 · Acc 0001104659-20-089591

Documents 1

  • SC 13G Amended Statement of Ownership , tm2026207d1_sc13g.htm

Around this filing

  • 2020-08-10 SC 13G Amended Statement of Ownership
  • 2020-08-03 SC 13G Amended Statement of Ownership
  • 2020-07-30 4 10% owner acquired 1,176,470 shares (conversion)
  • 2020-07-30 4 10% owner acquired 784,313 shares (conversion)
  • 2020-07-29 4 10% owner acquired 6,672,548 shares (conversion)
  • 2020-07-29 4 10% owner acquired 6,672,548 shares (conversion)
  • 2020-07-29 4 10% owner acquired 5,422,549 shares (conversion)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 5.49%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.55%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.4%
  5. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.4%
Loading tm2026207d1_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…